Ridgecrest Wealth Partners’s Labcorp LH Stock Holding History

Ridgecrest Wealth Partners’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,000	Closed	-$223K	–	114
2024 Q3	$223K	Hold	1,000	–	–	0.12%	101
2024 Q2	$204K	Hold	1,000	–	–	0.12%	99
2024 Q1	$218K	Hold	1,000	–	–	0.13%	96
2023 Q4	$227K	Hold	1,000	–	–	0.15%	91
2023 Q3	$201K	Sell	1,000 -164	-14%	-$34.6K	0.14%	92
2023 Q2	$241K	Hold	1,164	–	–	0.16%	87
2023 Q1	$229K	Hold	1,164	–	–	0.16%	87
2022 Q4	$235K	Hold	1,164	–	–	0.18%	80
2022 Q3	$205K	Sell	1,164 -12	-1%	-$2.46K	0.17%	88
2022 Q2	$237K	Hold	1,176	–	–	0.17%	91
2022 Q1	$266K	Hold	1,176	–	–	0.17%	92
2021 Q4	$317K	Hold	1,176	–	–	0.15%	99
2021 Q3	$284K	Hold	1,176	–	–	0.15%	97
2021 Q2	$279K	Buy	1,176 +12	+1%	+$2.73K	0.17%	89
2021 Q1	$255K	Buy	+1,164	New	+$234K	0.24%	74

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Ridgecrest Wealth Partners's LH Position: Q4 2024 in Review

Ridgecrest Wealth Partners sold out of Labcorp (LH) in Q4 2024, closing a stake of 1,000 shares — an estimated $223K sold.

Ridgecrest Wealth Partners first reported a position in LH in Q1 2021 and held it in 15 quarters. The position peaked at $317K in Q4 2021. 927 funds tracked by Wall St. Rank hold LH as of Q4 2024.

Ridgecrest Wealth Partners reported no remaining Labcorp position as of Q4 2024 after selling out during the quarter.
Ridgecrest Wealth Partners sold 1,000 Labcorp shares in Q4 2024, an estimated $223K.
Ridgecrest Wealth Partners first reported a position in Labcorp in Q1 2021 and held it in 15 quarters.
Ridgecrest Wealth Partners's Labcorp position peaked at $317K in Q4 2021.
927 funds tracked by Wall St. Rank held Labcorp as of Q4 2024.

Based on Ridgecrest Wealth Partners's 13F filing for Q4 2024, filed 22 Jan 2025.